📰 3 sources covering this story

AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, report says

First covered 1 hrs ago · latest take 11 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, report says
AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, report says
The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly US$400 billion.
CNBC
CNBC16 mins ago
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
Financial Times
Financial Times🏁 first to report1 hrs ago
AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
Tie-up would create one of the world’s biggest drugmakers
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →